S100A9 and neoplasm: Patients with an overall MST higher than that expected with conventional treatment (PSit02 and PSit04) showed an increase in MAC387+ cells in the primary tumor tissue after the administration of the OV, suggesting that ICOCAV15 could have an effect on the TME, further suggesting that the infiltration of these cells could improve survival.